Weekly Round Up

Research Deep DiveLong Form ArticleWeekly Round Up
Weekly Round UpWeekly Round Up
Where Healthcare Is Growing Fast... and Falling Behind

Where Healthcare Is Growing Fast... and Falling Behind

Wellness economics are booming — but TeleHealth still has a trust problem

Weekly Round UpWeekly Round Up
Telehealth Is Booming. Here’s What Comes Next.

Telehealth Is Booming. Here’s What Comes Next.

Telehealth’s trillion-dollar trajectory, 2026 tech budget priorities, and the engagement gap reshaping virtual care.

Weekly Round UpWeekly Round Up
GLP-1s Go Prime Time, Sub-$50M M&A Rebounds, and 67% Back Specialty Care

GLP-1s Go Prime Time, Sub-$50M M&A Rebounds, and 67% Back Specialty Care

Pharma pushes weight-loss drugs to the mass market and small deals clear 4 in 60 days, while India’s patient satisfaction drops to 46%.

Weekly Round UpWeekly Round Up
Who’s Winning in Healthcare Now: AI Megadeals, Staffing Giants & Telehealth Choices

Who’s Winning in Healthcare Now: AI Megadeals, Staffing Giants & Telehealth Choices

Deal count surges in healthcare AI and compliance tightens on staffing, while reliability drives 66% of telehealth platform decisions.

Weekly Round UpWeekly Round Up
AstraZeneca’s $15B Bet, €4bn Pharma Exit, and 36% Skip Care

AstraZeneca’s $15B Bet, €4bn Pharma Exit, and 36% Skip Care

AstraZeneca commits $15B to China and Permira eyes a €4bn sale of Neuraxpharm, while high costs force 36% of rural U.S. patients to forgo treatment.

Weekly Round UpWeekly Round Up
$9.9M HIPAA Fines, 50% Integration Pain, 78% Betting On AI

$9.9M HIPAA Fines, 50% Integration Pain, 78% Betting On AI

78% of leaders turn to AI for efficiency and $9.9M in HIPAA fines signals tougher enforcement, while integration complexity stalls virtual care for 50%.

Weekly Round UpWeekly Round Up
Healthcare M&A Under Pressure, Gavi Funding at Risk, and the Rise of Personalized Medicine

Healthcare M&A Under Pressure, Gavi Funding at Risk, and the Rise of Personalized Medicine

The U.S. conditions Gavi funding on thimerosal elimination and North America holds 45% of the personalized medicine market, while integration risk tops M&A concerns.

Weekly Round UpWeekly Round Up
Healthcare’s New Reality: $191B Deals, 61% More M&A, Rising Scrutiny

Healthcare’s New Reality: $191B Deals, 61% More M&A, Rising Scrutiny

Digital health funding rebounds 35% and 74% cite innovation as the top cost driver, while regulators target pharmacy supply chains.

Weekly Round UpWeekly Round Up
FDA–EMA Alignment, FemTech’s Regional Divide, and a $14.5B MedTech Bet

FDA–EMA Alignment, FemTech’s Regional Divide, and a $14.5B MedTech Bet

Boston Scientific acquires Penumbra for $14.5B and North America leads FemTech with 39% market share, while regulators set joint AI principles.

Weekly Round UpWeekly Round Up
Pharma’s 10.7% Bounce, AI’s 75% Promise & Rising $ Pressure

Pharma’s 10.7% Bounce, AI’s 75% Promise & Rising $ Pressure

After a 5-year lag, Pharma rebounds with 10.7% TSR while 23 states target drug pricing and 75% of leaders eye AI for admin efficiency.

Weekly Round UpWeekly Round Up
From HealthTech Deals to Mega Mergers: This Week in Healthcare

From HealthTech Deals to Mega Mergers: This Week in Healthcare

HealthTech M&A separates the scalable from the speculative and policy shifts top the 2026 agenda, while NYC sees a $2.2B hospital merger.

Weekly Round UpWeekly Round Up
What’s Holding Healthcare Back from AI Adoption?

What’s Holding Healthcare Back from AI Adoption?

This week we’re exploring the main barriers in AI adoption among Healthcare Systems.